China Broadband Capital (CBC Capital), LinkDoc Technology, China. Chemical synthetic and analytical methods (e.g. 81, SoftBank Group, Sinovation Ventures, New Oriental Education & Technology Group.Material sciences (e.g., polymers, ink materials, catalysts, semiconductor materials, magnetic materials, superconducting materials and formulations, fabric materials, and food additives and processing) Founded in 2014 in Beijing by Shan He and Tony Zhang, LinkDoc provides healthcare services that are steeped in big data and artificial intelligence (AI) to offer the latest in cancer-focused.Medical devices (e.g., stents, imaging devices, biosensors, and biochips).Spending the last 7 years creating the OptionsPlay tool, he is a leading educator on options and trading strategies around multiple world markets. Nutraceuticals (e.g., herbal extracts), drug formulations, cosmetic formulations (e.g., fragrance) Tony Zhang, Chief Strategy Officer of OptionsPlay and CNBC Contributor has over a decade of experience as a market strategist in equities, FX and derivatives.Pharmaceuticals (e.g., small molecule drugs and polymer-drug conjugates) First official ADIO China (Demi Ping RUIKUN JI) FDI delegation visiting AbuDhabi.His substantial patent prosecution experience spans chemistry, pharmaceuticals, material sciences, and biotechnology, including: School of Health and Biomedical Sciences PhD, MPH, BMed Connect with experts in your field Join ResearchGate to contact this researcher and connect with your.Tony's professional, educational, and research backgrounds have provided him with a deep understanding of a broad array of technical fields. Tony provides strategic counseling to clients, bringing a unique and well-rounded perspective of a skilled practitioner with in-depth technical and patent experience. Who are LinkDoc Technology 's competitors Alternatives and possible competitors to LinkDoc Technology may include Proscia, HealthVerity, and Securithings. Prior to co-founding Tyligand in 2018, he had served as Eli Lilly’s Sr. When was the last funding round for LinkDoc Technology LinkDoc Technology closed its last funding round on from a Series D round. ![]() His practice spans the IP life cycle, from helping clients understand and navigate the IP landscape as they bring new products to market to helping clients prune portfolios to divest low value assets. Tony Zhang had 25 years of experience leading pharmaceutical research and development.
0 Comments
Leave a Reply. |